[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69841550D1 - Behandlung von fibromyalgie und verwandten erkrankungen - Google Patents

Behandlung von fibromyalgie und verwandten erkrankungen

Info

Publication number
DE69841550D1
DE69841550D1 DE69841550T DE69841550T DE69841550D1 DE 69841550 D1 DE69841550 D1 DE 69841550D1 DE 69841550 T DE69841550 T DE 69841550T DE 69841550 T DE69841550 T DE 69841550T DE 69841550 D1 DE69841550 D1 DE 69841550D1
Authority
DE
Germany
Prior art keywords
fibromyalgia
treatment
related diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841550T
Other languages
English (en)
Inventor
Kathleen Arffmann
Merrill G Andrus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Designed Nutritional Products Inc
Original Assignee
Designed Nutritional Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Designed Nutritional Products Inc filed Critical Designed Nutritional Products Inc
Application granted granted Critical
Publication of DE69841550D1 publication Critical patent/DE69841550D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69841550T 1997-10-08 1998-10-07 Behandlung von fibromyalgie und verwandten erkrankungen Expired - Lifetime DE69841550D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/954,995 US5895787A (en) 1997-10-08 1997-10-08 Treatment of fibromyalgia and related disorders
PCT/US1998/021190 WO1999017768A1 (en) 1997-10-08 1998-10-07 Treatment of fibromyalgia and related disorders

Publications (1)

Publication Number Publication Date
DE69841550D1 true DE69841550D1 (de) 2010-04-22

Family

ID=25496218

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841550T Expired - Lifetime DE69841550D1 (de) 1997-10-08 1998-10-07 Behandlung von fibromyalgie und verwandten erkrankungen

Country Status (5)

Country Link
US (1) US5895787A (de)
EP (1) EP1030663B1 (de)
CA (1) CA2306748C (de)
DE (1) DE69841550D1 (de)
WO (1) WO1999017768A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613792B1 (en) * 1999-08-02 2003-09-02 Designed Nutritional Products, Inc. Treatment of premenstrual syndrome and menopause
US6689387B1 (en) * 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis
US7384971B2 (en) * 1999-09-23 2008-06-10 Bioresponse L.L.C. Phytochemicals for the treatment of cervical dysplasia
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
EP1095658A3 (de) * 1999-10-27 2002-10-23 Bioenergy Inc. Verwendung von Ribose zur Behandlung der Fibromyalgie
US6399645B1 (en) 2000-03-20 2002-06-04 Maria Bell Chemoprevention and treatment of cervical or vaginal neoplasia
WO2001081307A2 (en) * 2000-04-26 2001-11-01 Wisconsin Alumni Research Foundation Triaryl cation antibiotics from environmental dna
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
US6436448B1 (en) 2001-06-25 2002-08-20 Sky Biohealth Solutions, Inc. Method for the treatment of lymphedema using guaifenesin
US7348352B2 (en) * 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
US20040092504A1 (en) * 2002-11-12 2004-05-13 Anuthep Benja-Athon Definitive medications for treating fibromyalgia
BRPI0510717B8 (pt) * 2004-05-06 2021-05-25 Bioresponse Llc uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)
EP1838303B1 (de) 2004-12-30 2011-02-09 Bioresponse LLC Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
WO2007112963A1 (en) * 2006-03-31 2007-10-11 Dsm Ip Assets B.V. Novel use of ascorbigen
WO2008057253A2 (en) 2006-10-27 2008-05-15 Bioresponse, L.L.C. Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428962A (en) * 1981-10-30 1984-01-31 Schering Corporation Indoles in treatment of peptic ulcers
US4877798A (en) * 1987-11-23 1989-10-31 Merrell Dow Pharmaceuticals Inc. Treatment of fibromyalgia
US5206377A (en) * 1991-12-05 1993-04-27 Whitby Research, Inc. Compounds useful as antiproliferative agents
US5300645A (en) * 1993-04-14 1994-04-05 Eli Lilly And Company Tetrahydro-pyrido-indole
EP0620222A3 (de) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-betacarboline.
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
US5658955A (en) * 1994-11-01 1997-08-19 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of immune disorders
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone

Also Published As

Publication number Publication date
US5895787A (en) 1999-04-20
EP1030663A1 (de) 2000-08-30
WO1999017768A1 (en) 1999-04-15
CA2306748A1 (en) 1999-04-15
EP1030663B1 (de) 2010-03-10
CA2306748C (en) 2010-12-21
EP1030663A4 (de) 2002-06-26

Similar Documents

Publication Publication Date Title
ATE399016T1 (de) Vorbeugung und behandlung von amyloidogener krankheit
DE69500089D1 (de) Behandlung von Geflügel
ATE349216T1 (de) Behandlung von darmverstopfung
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE434444T1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69926385D1 (de) Behandlung von geweben
DE69817446D1 (de) Behandlung von diabetes
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE69024039D1 (de) Behandlung von pathologischen zuständen und krankheiten.
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69810499D1 (de) Behandlung von industriegeweben
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
DE69520268D1 (de) Behandlung von Legierungen und danach hergestellte Gegenstände
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition